Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 376

1.

The association between the inflammatory response to surgery and postoperative complications in older patients with cancer; a prospective prognostic factor study.

Plas M, Rutgers A, van der Wal-Huisman H, de Haan JJ, Absalom AR, de Bock GH, van Leeuwen BL.

J Geriatr Oncol. 2020 Feb 5. pii: S1879-4068(19)30447-3. doi: 10.1016/j.jgo.2020.01.013. [Epub ahead of print]

PMID:
32035801
2.

Before it catches the eye….

Mourits MJ, de Bock GH.

Ann Transl Med. 2019 Dec;7(Suppl 8):S274. doi: 10.21037/atm.2019.11.150. No abstract available.

3.

Comparison of health behaviours between cancer survivors and the general population: a cross-sectional analysis of the Lifelines cohort.

Cortés-Ibáñez FO, Jaramillo-Calle DA, Vinke PC, Byambasukh O, Corpeleijn E, Sijtsma A, Eulenburg C, Vonk JM, de Bock GH.

J Cancer Surviv. 2020 Jan 14. doi: 10.1007/s11764-020-00854-2. [Epub ahead of print]

PMID:
31933151
4.

The association of preoperative anxiety and depression with neurocognitive disorder following oncological surgery.

Du J, Plas M, Absalom AR, van Leeuwen BL, de Bock GH.

J Surg Oncol. 2020 Jan 12. doi: 10.1002/jso.25836. [Epub ahead of print]

PMID:
31930514
5.

Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population.

Cui X, Heuvelmans MA, Han D, Zhao Y, Fan S, Zheng S, Sidorenkov G, Groen HJM, Dorrius MD, Oudkerk M, de Bock GH, Vliegenthart R, Ye Z.

Transl Lung Cancer Res. 2019 Oct;8(5):605-613. doi: 10.21037/tlcr.2019.09.17.

6.

Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS.

Kok LMC, Bungener L, de Bock GH, Biswana A, van der Wal G, van Imhoff GW, Bellido M.

Hum Cell. 2020 Jan;33(1):243-251. doi: 10.1007/s13577-019-00297-7. Epub 2019 Nov 15.

7.

The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective.

Sidorenkov G, Nagel J, Meijer C, Duker JJ, Groen HJM, Halmos GB, Oonk MHM, Oostergo RJ, van der Vegt B, Witjes MJH, Nijland M, Havenga K, Maduro JH, Gietema JA, de Bock GH.

J Transl Med. 2019 Nov 14;17(1):374. doi: 10.1186/s12967-019-2122-x.

8.

Long-term psychological distress in breast cancer survivors and their matched controls: A cross-sectional study.

Maass SWMC, Boerman LM, Verhaak PFM, Du J, de Bock GH, Berendsen AJ.

Maturitas. 2019 Dec;130:6-12. doi: 10.1016/j.maturitas.2019.09.003. Epub 2019 Sep 16.

PMID:
31706438
9.

Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer.

van der Sluis FJ, Couwenberg AM, de Bock GH, Intven MPW, Reerink O, van Leeuwen BL, van Westreenen HL.

Br J Surg. 2020 Jan;107(1):131-139. doi: 10.1002/bjs.11324. Epub 2019 Oct 17.

PMID:
31625143
10.

Patients with head and neck cancer: Are they frailer than patients with other solid malignancies?

Bras L, Driessen DAJJ, de Vries J, Festen S, van der Laan BFAM, van Leeuwen BL, de Bock GH, Halmos GB.

Eur J Cancer Care (Engl). 2020 Jan;29(1):e13170. doi: 10.1111/ecc.13170. Epub 2019 Sep 30.

PMID:
31571340
11.

Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.

Kop E, de Bock GH, Noordhuis MG, Slagter-Menkema L, van der Laan BFAM, Langendijk JA, Schuuring E, van der Vegt B.

Clin Otolaryngol. 2020 Jan;45(1):12-20. doi: 10.1111/coa.13449. Epub 2019 Nov 5.

12.

Geriatric assessment of patients treated for cutaneous head and neck malignancies in a tertiary referral center: Predictors of postoperative complications.

de Vries J, Heirman AN, Bras L, Plaat BEC, Rácz E, van Kester MS, Festen S, de Bock GH, van der Laan BFAM, Halmos GB.

Eur J Surg Oncol. 2020 Jan;46(1):123-130. doi: 10.1016/j.ejso.2019.08.008. Epub 2019 Aug 10.

PMID:
31427138
13.

GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis.

Gruppen EG, Kunutsor SK, Kieneker LM, van der Vegt B, Connelly MA, de Bock GH, Gansevoort RT, Bakker SJL, Dullaart RPF.

J Intern Med. 2019 Nov;286(5):596-609. doi: 10.1111/joim.12953. Epub 2019 Jul 24.

14.

CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.

Zwart AT, van der Hoorn A, van Ooijen PMA, Steenbakkers RJHM, de Bock GH, Halmos GB.

J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1060-1069. doi: 10.1002/jcsm.12443. Epub 2019 May 27.

15.

Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study.

Du Y, Zhao Y, Sidorenkov G, de Bock GH, Cui X, Huang Y, Dorrius MD, Rook M, Groen HJM, Heuvelmans MA, Vliegenthart R, Chen K, Xie X, Liu S, Oudkerk M, Ye Z.

Cancer Biol Med. 2019 Feb;16(1):181-188. doi: 10.20892/j.issn.2095-3941.2018.0237.

16.

Margin status revisited in vulvar squamous cell carcinoma.

Te Grootenhuis NC, Pouwer AW, de Bock GH, Hollema H, Bulten J, van der Zee AGJ, de Hullu JA, Oonk MHM.

Gynecol Oncol. 2019 Aug;154(2):266-275. doi: 10.1016/j.ygyno.2019.05.010. Epub 2019 May 18.

PMID:
31109660
17.

The systemic impact of a surgical procedure in older oncological patients.

Plas M, de Haan JJ, van der Wal-Huisman H, Rutgers A, Absalom AR, de Bock GH, van Leeuwen BL.

Eur J Surg Oncol. 2019 Aug;45(8):1403-1409. doi: 10.1016/j.ejso.2019.04.024. Epub 2019 May 3.

PMID:
31104780
18.

How to incorporate geriatric assessment in clinical decision-making for older patients with cancer. An implementation study.

Festen S, Kok M, Hopstaken JS, van der Wal-Huisman H, van der Leest A, Reyners AKL, de Bock GH, de Graeff P, van Leeuwen BL.

J Geriatr Oncol. 2019 Nov;10(6):951-959. doi: 10.1016/j.jgo.2019.04.006. Epub 2019 Apr 26.

PMID:
31031193
19.

Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study.

Xia C, Rook M, Pelgrim GJ, Sidorenkov G, Wisselink HJ, van Bolhuis JN, van Ooijen PMA, Guo J, Oudkerk M, Groen H, van den Berge M, van der Harst P, Dijkstra H, Vonder M, Heuvelmans MA, Dorrius MD, De Deyn PP, de Bock GH, Dotinga A, Vliegenthart R.

Eur J Epidemiol. 2019 Apr 23. doi: 10.1007/s10654-019-00519-0. [Epub ahead of print]

PMID:
31016436
20.

Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients.

Hilberink J, Hazenberg C, van den Berg E, Mulder A, Schuringa JJ, van der Helm L, de Groot M, Choi G, de Bock GH, Vellenga E, Ammatuna E, Huls G.

Leuk Res. 2019 May;80:33-39. doi: 10.1016/j.leukres.2019.03.004. Epub 2019 Mar 18.

21.

Determinants of health-related quality of life in elderly ovarian cancer patients: The role of frailty and dependence.

de Arruda FN, Oonk MHM, Mourits MJE, de Graeff P, Jalving M, de Bock GH.

Gynecol Oncol. 2019 Jun;153(3):610-615. doi: 10.1016/j.ygyno.2019.03.249. Epub 2019 Mar 29.

PMID:
30935716
22.

Acceptance of contralateral reduction mammoplasty after oncoplastic breast conserving surgery: A semi-structured qualitative interview study.

Smeele HP, Van der Does de Willebois EML, Eltahir Y, De Bock GH, Van Aalst VC, Jansen L.

Breast. 2019 Jun;45:97-103. doi: 10.1016/j.breast.2019.03.008. Epub 2019 Mar 25.

PMID:
30928763
23.

Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.

Phi XA, Greuter MJW, Obdeijn IM, Oosterwijk JC, Feenstra TL, Houssami N, de Bock GH.

Breast. 2019 Jun;45:82-88. doi: 10.1016/j.breast.2019.03.004. Epub 2019 Mar 12.

PMID:
30904701
24.

Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.

Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK.

Gastric Cancer. 2019 Sep;22(5):920-931. doi: 10.1007/s10120-019-00945-9. Epub 2019 Mar 20.

25.

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial.

de Hosson LD, Bouma G, Stelwagen J, van Essen H, de Bock GH, de Groot DJA, de Vries EGE, Walenkamp AME.

Orphanet J Rare Dis. 2019 Feb 28;14(1):60. doi: 10.1186/s13023-019-1035-3.

26.

Cardiac Function After Radiation Therapy for Breast Cancer.

van den Bogaard VAB, van Luijk P, Hummel YM, van der Meer P, Schuit E, Boerman LM, Maass SWMC, Nauta JF, Steggink LC, Gietema JA, de Bock GH, Berendsen AJ, Smit WGJM, Sijtsema NM, Kierkels RGJ, Langendijk JA, Crijns APG, Maduro JH.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):392-400. doi: 10.1016/j.ijrobp.2019.02.003. Epub 2019 Feb 11.

PMID:
30763659
27.

The Effect of Smoking and Body Mass Index on The Complication Rate of Alloplastic Breast Reconstruction.

Sadok N, Krabbe-Timmerman IS, de Bock GH, Werker PMN, Jansen L.

Scand J Surg. 2019 Feb 3:1457496919826711. doi: 10.1177/1457496919826711. [Epub ahead of print]

PMID:
30712467
28.

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study.

Leimkühler M, Hemmer PHJ, Reyners AKL, de Groot DJA, van Ginkel RJ, Been LB, de Bock GH, van Leeuwen BL.

World J Surg Oncol. 2019 Jan 11;17(1):14. doi: 10.1186/s12957-018-1554-8.

29.

Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01.

De Moerloose B, Reedijk A, de Bock GH, Lammens T, de Haas V, Denys B, Dedeken L, van den Heuvel-Eibrink MM, Te Loo M, Uyttebroeck A, Van Damme A, Van der Werff-Ten Bosch J, Zsiros J, Kaspers G, de Bont E.

Pediatr Blood Cancer. 2019 May;66(5):e27605. doi: 10.1002/pbc.27605. Epub 2019 Jan 8.

PMID:
30623572
30.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.

PMID:
30591535
31.

Age should not be a limiting factor in laparoscopic surgery: a prospective multicenter cohort study on quality of life after laparoscopic hysterectomy.

Briët JM, Mourits MJ, van Leeuwen BL, van den Heuvel ER, Kenkhuis MJ, Arts HJ, de Bock GH.

Clin Interv Aging. 2018 Dec 13;13:2517-2526. doi: 10.2147/CIA.S172965. eCollection 2018.

32.

What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.

Koopman T, Buikema HJ, Hollema H, de Bock GH, van der Vegt B.

Histopathology. 2019 May;74(6):917-924. doi: 10.1111/his.13812. Epub 2019 Apr 1.

33.

Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.

Heuvelmans MA, Vonder M, Rook M, Groen HJM, De Bock GH, Xie X, Ijzerman MJ, Vliegenthart R, Oudkerk M.

J Thorac Imaging. 2019 May;34(3):160-169. doi: 10.1097/RTI.0000000000000379. Review.

PMID:
30550403
34.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, Nackaerts K, van Ooijen PMA, de Koning HJ, Vliegenthart R, Oudkerk M.

Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14.

35.

Long-Term Survival in Octogenarians After Surgical Treatment for Colorectal Cancer: Prevention of Postoperative Complications is Key.

Weerink LBM, Gant CM, van Leeuwen BL, de Bock GH, Kouwenhoven EA, Faneyte IF.

Ann Surg Oncol. 2018 Dec;25(13):3874-3882. doi: 10.1245/s10434-018-6766-1. Epub 2018 Sep 22.

36.

Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial.

van Driel C, de Bock GH, Schroevers MJ, Mourits MJ.

BJOG. 2019 Feb;126(3):402-411. doi: 10.1111/1471-0528.15471. Epub 2018 Oct 23.

37.

Quality of Life and Sexual Functioning After Vulvar Reconstruction With the Lotus Petal Flap.

Hellinga J, Te Grootenhuis NC, Werker PMN, de Bock GH, van der Zee AGJ, Oonk MHM, Stenekes MW.

Int J Gynecol Cancer. 2018 Nov;28(9):1728-1736. doi: 10.1097/IGC.0000000000001340. Erratum in: Int J Gynecol Cancer. 2019 Sep;29(7):1230.

PMID:
30157166
38.

L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition.

Versluis M, Plat A, de Bruyn M, Matias-Guiu X, Trovic J, Krakstad C, Nijman HW, Bosse T, de Bock GH, Hollema H.

Virchows Arch. 2018 Nov;473(5):591-598. doi: 10.1007/s00428-018-2444-8. Epub 2018 Aug 23.

PMID:
30140948
39.

Optimal unidirectional switch designs.

Zhan Z, de Bock GH, van den Heuvel ER.

Stat Med. 2018 Nov 10;37(25):3573-3588. doi: 10.1002/sim.7853. Epub 2018 Jul 12.

PMID:
30003557
40.

HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.

Koopman T, van der Vegt B, Dijkstra M, Bart J, Duiker E, Wisman GBA, de Bock GH, Hollema H.

Histopathology. 2018 Nov;73(5):852-863. doi: 10.1111/his.13704. Epub 2018 Sep 19.

PMID:
29989198
41.

Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.

Teixeira N, Mourits MJ, Oosterwijk JC, Fakkert IE, Absalom AR, Bakker SJL, van der Meer P, de Bock GH.

Fam Cancer. 2019 Jan;18(1):19-27. doi: 10.1007/s10689-018-0091-5.

42.

Characteristics of Lynch syndrome associated ovarian cancer.

Woolderink JM, De Bock GH, de Hullu JA, Hollema H, Zweemer RP, Slangen BFM, Gaarenstroom KN, van Beurden M, van Doorn HC, Sijmons RH, Vasen HFA, Mourits MJE.

Gynecol Oncol. 2018 Aug;150(2):324-330. doi: 10.1016/j.ygyno.2018.03.060. Epub 2018 Jun 5.

PMID:
29880284
43.

Corrigendum to "A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening" [Maturitas 109 (2018) 81-88].

Koleva-Kolarova RG, Daszczuk AM, de Jonge C, Abu Hantash MK, Zhan ZZ, Postema EJ, Feenstra TL, Pijnappel RM, Greuter MJW, de Bock GH.

Maturitas. 2018 Aug;114:73. doi: 10.1016/j.maturitas.2018.05.005. Epub 2018 May 17. No abstract available.

PMID:
29779854
44.

Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study.

Koleva-Kolarova RG, Greuter MJW, Feenstra TL, Vermeulen KM, de Vries EFJ, Parkin D, Buskens E, de Bock GH.

Oncotarget. 2018 Apr 13;9(28):19836-19846. doi: 10.18632/oncotarget.24869. eCollection 2018 Apr 13.

45.

Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.

Vos M, Plasmeijer EI, van Bemmel BC, van der Bij W, Klaver NS, Erasmus ME, de Bock GH, Verschuuren EAM, Rácz E.

J Heart Lung Transplant. 2018 Jul;37(7):853-859. doi: 10.1016/j.healun.2018.03.012. Epub 2018 Mar 19.

PMID:
29680587
46.

Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.

Stuursma A, van Driel CMG, Wessels NJ, de Bock GH, Mourits MJE.

Maturitas. 2018 May;111:69-76. doi: 10.1016/j.maturitas.2018.01.012. Epub 2018 Jan 13.

PMID:
29673834
47.

Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review.

Spronk I, Schellevis FG, Burgers JS, de Bock GH, Korevaar JC.

Breast. 2018 Jun;39:70-79. doi: 10.1016/j.breast.2018.03.011. Epub 2018 Apr 2. Review.

PMID:
29621695
48.

Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts - a systematic review and meta-analysis.

Phi XA, Tagliafico A, Houssami N, Greuter MJW, de Bock GH.

BMC Cancer. 2018 Apr 3;18(1):380. doi: 10.1186/s12885-018-4263-3. Review.

49.

Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?

de Munck L, Fracheboud J, de Bock GH, den Heeten GJ, Siesling S, Broeders MJM.

Int J Cancer. 2018 Aug 15;143(4):842-850. doi: 10.1002/ijc.31388. Epub 2018 Apr 6.

50.

High-pitch versus sequential mode for coronary calcium in individuals with a high heart rate: Potential for dose reduction.

Vonder M, Vliegenthart R, Kaatee MA, van der Aalst CM, van Ooijen PMA, de Bock GH, Gratama JW, Kuijpers D, de Koning HJ, Oudkerk M.

J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):298-304. doi: 10.1016/j.jcct.2018.02.005. Epub 2018 Mar 1.

PMID:
29551663

Supplemental Content

Loading ...
Support Center